Atlas Trials

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Clinical trial NCT00452621 · COMPLETED

Trial details

NCT number
NCT00452621
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Encephalitis, Tick-Borne
Start date
2007-02-01
Enrollment
235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.